Resistance to endocrine therapy in breast cancer: molecular mechanisms and future goals
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7217
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Resistance to endocrine therapy in breast cancer: molecular mechanisms and future goals ; day:1 ; month:11 ; year:2018 ; pages:1-9
Breast cancer research and treatment ; (1.11.2018), 1-9
- Urheber
-
Szostakowska, Małgorzata
Trębińska-Stryjewska, Alicja
Grzybowska, Ewa Anna
Fabisiewicz, Anna
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10549-018-5023-4
- URN
-
urn:nbn:de:101:1-2018122019100405575828
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Szostakowska, Małgorzata
- Trębińska-Stryjewska, Alicja
- Grzybowska, Ewa Anna
- Fabisiewicz, Anna
- SpringerLink (Online service)
Ähnliche Objekte (12)
Hormone resistance and other endocrine paradoxes
Stackless: Recent advancements and future goals
Genetic mechanisms in multiple endocrine neoplasia type 2
GLYATL1 PROMOTES ENDOCRINE THERAPY RESISTANCE IN BREAST CANCER
Endocrine therapy: defining the path of least resistance
VAV3 mediates resistance to breast cancer endocrine therapy
Future software organizations – agile goals and roles
Endocrine and metabolic mechanisms regulating systemic and central inflammation
Clonal heterogeneity of endocrine therapy resistance in breast cancer
Mechanisms of endocrine disruption in caenogastropods - androgenic and estrogenic pathways
Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective
Endocrine
Hormone resistance and other endocrine paradoxes
Stackless: Recent advancements and future goals
Genetic mechanisms in multiple endocrine neoplasia type 2
GLYATL1 PROMOTES ENDOCRINE THERAPY RESISTANCE IN BREAST CANCER
Endocrine therapy: defining the path of least resistance
VAV3 mediates resistance to breast cancer endocrine therapy
Future software organizations – agile goals and roles
Endocrine and metabolic mechanisms regulating systemic and central inflammation
Clonal heterogeneity of endocrine therapy resistance in breast cancer
Mechanisms of endocrine disruption in caenogastropods - androgenic and estrogenic pathways
Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective
Endocrine
Hormone resistance and other endocrine paradoxes
Stackless: Recent advancements and future goals
Genetic mechanisms in multiple endocrine neoplasia type 2
GLYATL1 PROMOTES ENDOCRINE THERAPY RESISTANCE IN BREAST CANCER
Endocrine therapy: defining the path of least resistance
VAV3 mediates resistance to breast cancer endocrine therapy
Future software organizations – agile goals and roles
Endocrine and metabolic mechanisms regulating systemic and central inflammation
Clonal heterogeneity of endocrine therapy resistance in breast cancer
Mechanisms of endocrine disruption in caenogastropods - androgenic and estrogenic pathways
Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective